What Is End-of-Life Care for Glioblastoma (GBM) at Recurrence?
By CRYSTAL BAI •
The short answer: Recurrent glioblastoma (GBM) at first or second recurrence has limited treatment options and a median survival of 6–9 months. End-of-life care prioritizes functional quality of life, seizure control, steroid management, and family support through a disease that profoundly affects cognition and personhood.
Understanding Recurrent GBM at End of Life
Glioblastoma (GBM, WHO grade IV) is the most common malignant primary brain tumor in adults, with a median overall survival of 15–20 months with standard treatment (surgery, temozolomide, radiation). At first recurrence, options include bevacizumab, lomustine, re-irradiation, and tumor treating fields — but none are curative and median OS at recurrence is 6–9 months.
The Unique Palliative Challenges of GBM
GBM's location in the brain creates unique end-of-life challenges that other cancers don't share: progressive cognitive decline, personality changes, seizures, aphasia, and eventual loss of awareness and communication. These changes affect not only the patient but profoundly challenge the identity of the person and the experience of family members witnessing the transformation.
Steroid Management at End of Life
Dexamethasone is commonly used to control brain edema and preserve neurological function. As GBM progresses, steroid doses often must increase — with associated side effects (hyperglycemia, mood changes, insomnia, weight gain). End-of-life steroid tapering decisions require careful weighing of symptom control versus quality-of-life impact.
Cognitive and Personality Changes: Family Support
When GBM causes personality changes, cognitive decline, or aphasia, family members experience a specific grief — they are losing the person while the person is still physically alive. Anticipatory grief, ambiguous loss, and family caregiver support are essential dimensions of GBM palliative care that require specific attention.
Frequently Asked Questions
What is recurrent glioblastoma?
Recurrent GBM is glioblastoma that returns after initial treatment. At recurrence, options are limited and median survival is 6–9 months, making early palliative planning essential.
When should a GBM patient consider hospice?
Hospice is appropriate when GBM has recurred and further treatment is not viable or desired, prognosis is six months or less, and the goal is quality of life.
How does GBM affect personhood and family relationships?
GBM can cause personality changes, cognitive decline, and communication loss — creating a unique anticipatory grief for families watching their loved one transform before death.
Can a death doula help a family facing GBM?
Yes. Death doulas provide crucial family support, help navigate the unique dimensions of brain cancer end of life, and offer companionship to patients and caregivers during GBM's challenging trajectory.
Renidy connects grieving families with compassionate death doulas and AI-powered funeral planning tools. Try our free AI funeral planner or find a death doula near you.